1. Academic Validation
  2. GC-MS analysis of the designer drug α-pyrrolidinovalerophenone and its metabolites in urine and blood in an acute poisoning case

GC-MS analysis of the designer drug α-pyrrolidinovalerophenone and its metabolites in urine and blood in an acute poisoning case

  • Forensic Sci Int. 2016 Feb:259:e14-9. doi: 10.1016/j.forsciint.2015.12.020.
Marcel Grapp 1 Christoph Sauer 2 Christian Vidal 3 Dieter Müller 4
Affiliations

Affiliations

  • 1 Forensic Toxicological Laboratory, University Medical Center Göttingen, Georg-August-University, 37075 Göttingen, Germany. Electronic address: mgrapp@med.uni-goettingen.de.
  • 2 Institute of Legal Medicine, University Hospital Jena, 07740 Jena, Germany.
  • 3 State Criminal Police Office Niedersachsen, Forensic Science Institute, 30169 Hannover, Germany.
  • 4 GIZ-Nord Poisons Center, University Medical Center Göttingen, Georg-August-University, 37075 Göttingen, Germany.
Abstract

α-Pyrrolidinovalerophenone (α-PVP) is a synthetic cathinone belonging to the group of "second generation" pyrrolidinophenones that becomes more and more popular as a designer psychostimulant. Here we provide toxicological analytical support for a severe poisoning with α-PVP. Serum and urine samples that were sent to our laboratory were subjected to a general unknown screening procedure. The procedure includes immunoassay-based screening of drugs of abuse in serum and systematic toxicological analysis of urine and serum after neutral and basic liquid-liquid extraction followed by gas chromatography-mass spectrometry (GC-MS). Whereas the immunoassay delivered negative results, analyzing the urine sample by GC-MS in full scan mode disclosed the presence of α-PVP and its metabolites α-(2″-oxo-pyrrolidino)valerophenone (2″-oxo-α-PVP) and 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-ol (OH-α-PVP). In the acetylated urine sample we found additionally N,N-bis-dealkyl-PVP. In serum, α-PVP could be detected after solid phase extraction and a concentration of 29ng/mL was determined. Other forensic relevant substances were not detected. The presented data can explain the psychotic symptoms and behavioural pattern of the subject after abuse of α-PVP, leading to a clinical condition similar to excited delirium syndrome.

Keywords

Designer drug; Gas chromatography–mass spectrometry; General unknown screening; Pyrrolidinophenone; α-Pyrrolidinovalerophenone.

Figures
Products